Ignite Creation Date:
2024-05-06 @ 9:21 AM
Last Modification Date:
2024-10-26 @ 12:13 PM
Study NCT ID:
NCT02964494
Status:
RECRUITING
Last Update Posted:
2024-01-10
First Post:
2016-10-04
Brief Title:
The Congenital Dyserythropoietic Anemia Registry CDAR
Sponsor:
Organization:
Childrens Hospital Medical Center Cincinnati
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
15 Years
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Subject DNA isolated from subjects oral cells or blood or other biological samples donated to be used for gene sequencing diagnostic studies evaluate for known or novel genes that may be causative of CDA
Bone marrow will be collected ONLY when bone marrow samples are being collected for standard diagnostic or treatment related reasons No interventional procedure other than a voluntary blood draw if patient consents is required as part of the CDAR Registry
Enrollment Count:
10000
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Other |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 38085 |
Who Masked List: